4/24
04:14 pm
tcrx
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
Low
Report
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
4/24
04:05 pm
tcrx
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Low
Report
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
4/24
11:03 am
tcrx
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
Medium
Report
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
4/23
01:33 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
4/22
05:13 pm
tcrx
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]
Low
Report
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]
4/22
05:01 pm
tcrx
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Low
Report
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
4/19
10:10 am
tcrx
TScan Therapeutics Announces Closing of Upsized Public Offering [Yahoo! Finance]
Low
Report
TScan Therapeutics Announces Closing of Upsized Public Offering [Yahoo! Finance]
4/19
10:05 am
tcrx
TScan Therapeutics Announces Closing of Upsized Public Offering
Medium
Report
TScan Therapeutics Announces Closing of Upsized Public Offering
4/17
03:11 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
4/17
03:40 am
tcrx
TScan Therapeutics prices upsized stock offering to raise $150 million [Seeking Alpha]
Medium
Report
TScan Therapeutics prices upsized stock offering to raise $150 million [Seeking Alpha]
4/17
12:30 am
tcrx
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Medium
Report
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
4/16
04:27 pm
tcrx
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering [Yahoo! Finance]
Medium
Report
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering [Yahoo! Finance]
4/16
04:25 pm
tcrx
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Medium
Report
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
4/16
04:19 pm
tcrx
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities [Yahoo! Finance]
Medium
Report
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities [Yahoo! Finance]
4/16
04:01 pm
tcrx
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
Medium
Report
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
4/8
08:14 am
tcrx
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer [Yahoo! Finance]
Medium
Report
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer [Yahoo! Finance]
4/8
08:00 am
tcrx
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
Medium
Report
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
4/2
07:05 am
tcrx
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
High
Report
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/2
07:00 am
tcrx
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
High
Report
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
3/26
09:07 am
tcrx
Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16% [Yahoo! Finance]
Low
Report
Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16% [Yahoo! Finance]
3/7
01:53 pm
tcrx
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline [Yahoo! Finance]
Low
Report
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline [Yahoo! Finance]
3/6
11:54 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
3/6
10:34 am
tcrx
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/6
07:12 am
tcrx
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/6
07:00 am
tcrx
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update